Drug Trial News

RSS

New treatment for warts

A clinical trial treating the papillomaviruses responsible for genital warts was on target at the halfway mark, according to Australian of the Year 2006 Professor Ian Frazer and trial manager, sexual health specialist Dr David Jardine

10 May 2007

Cell-derived scaffold reproduction of cartilage tissue

A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue.

10 May 2007

Theophylline offers relief for unexplained chest pain

The discomfort caused by esophageal (non-cardiac) chest pain is often severe, driving many patients to emergency rooms and physicians' offices despite the fact that the ailment has no definable pathology.

10 May 2007

Omega-3 fatty acids may lower risk of Alzheimer's

Nutritionists have long endorsed fish as part of a heart-healthy diet, and now some studies suggest that omega-3 fatty acids found in the oil of certain fish may also benefit the brain by lowering the risk of Alzheimer's disease.

10 May 2007

Many herb users don't follow scientific guidelines

Sales of herbal dietary supplements have skyrocketed by 100 percent in the United States during the last 10 years, but most people don't consider evidence-based indications before using them, according to a University of Iowa study published in this month's Mayo Clinic Proceedings.

10 May 2007

The financial impact of a brain tumor diagnosis on patients and families

A new study released by the National Brain Tumor Foundation, The Financial Impact of a Brain Tumor Diagnosis on Patients and Families, reveals that the financial impact for patients suffering from brain tumors is devastating and life-changing.

10 May 2007

FluForecast trial predicted high human H5N1 mortality in Indonesia

When H5N1 was thought to be quiescent in 2006, in a prospective open trial, FluForecast, a software program which measures virus gene proteins, predicted high human mortality H5N1 outbreaks to come.

10 May 2007

FDG-PET imaging predicts lung cancer patients' response to chemotherapy

An earlier indication of whether chemotherapy benefits non-small cell lung cancer patients, provided by positron emission tomography (PET) imaging, can guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine.

10 May 2007

Fine motor skills, social acceptance lower in children with 'lazy eye'

A recent study evaluating the fine motor skills and perceived self esteem of children with amblyopia (or "lazy eye") compared with age-matched children will be presented during the Association for Research in Vision and Ophthalmology (ARVO) 2007 Annual Meeting in Fort Lauderdale, Fla.

10 May 2007

Review of six large-scale clinical trials of aliskiren

Hypertension is a serious condition affecting millions.Currently there are seven classes of drugs used to reduce blood pressure. Aliskiren (Tekturna , Rasilez) is the first of a new class of orally active antihypertensive drugs that works by inhibiting renin.

10 May 2007

Coarse particulate matter in outdoor air raises bad cholesterol

Breathing air containing coarse particulate matter such as road or construction dust may cause heart problems for asthma sufferers and other vulnerable populations, according to a new study led by the University of North Carolina at Chapel Hill School of Public Health.

10 May 2007

Assessment of state immunization requirements for healthcare workers and patients

A new study shows wide state-to-state variations in laws regulating vaccinations for health care workers and patients, setting the stage for future research to determine whether more laws could serve as effective tools to combat infectious diseases.

9 May 2007

Movies significantly influence teens to smoke

Two new studies by Dartmouth Medical School pediatrician researchers underscore the significant impact that movies have in influencing teens to smoke.

9 May 2007

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

9 May 2007

Stress of deployment increases risk of child abuse, neglect in military families

Rates of abuse and neglect of young children in military families in Texas has doubled since October 2002, a University of North Carolina at Chapel Hill study shows, raising concerns about the impact of deployment on military personnel and their families across the country.

9 May 2007

Rosuvastatin well tolerated by a broad range of patients with dyslipidemia

The safety and tolerability of rosuvastatin were assessed using data from 16,876 patients who received rosuvastatin 5-40 mg in a multinational phase II/III/IIIb/IV program, representing 25,670 patient-years of continuous exposure to rosuvastatin. An integrated database, consisting of 33 trials whose databases were locked up to and including September 16, 2005, was used to examine adverse events and laboratory data.

9 May 2007

The influence of diluent warming on dantrolene sodium mixing time

Every second counts for anesthesia patients afflicted by the often deadly condition known as malignant hyperthermia (MH).

9 May 2007

Off-label and untested use of drug-coated stents is common in U.S. practice

The off-label and untested use of drug-coated stents in the treatment of coronary artery blockage is common in U.S. practice, and ischemic complication rates are higher among patients receiving drug-coated stents for off-label indications, according to two studies in the May 9 issue of Journal of the American Medical Association.

9 May 2007

Adverse outcomes associated with unapproved uses of drug-coated stents

Research led by a team at the Methodist DeBakey Heart Center sheds light on what happens to high-risk patients who receive drug-coated stents off-label to open clogged arteries, as reported in today's Journal of the American Medical Association (JAMA) .

9 May 2007